| Product NDC: | 0093-7618 |
| Proprietary Name: | Dorzolamide Hydrochloride |
| Non Proprietary Name: | Dorzolamide Hydrochloride |
| Active Ingredient(s): | 20 mg/mL & nbsp; Dorzolamide Hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-7618 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078756 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100128 |
| Package NDC: | 0093-7618-43 |
| Package Description: | 1 BOTTLE in 1 CARTON (0093-7618-43) > 10 mL in 1 BOTTLE |
| NDC Code | 0093-7618-43 |
| Proprietary Name | Dorzolamide Hydrochloride |
| Package Description | 1 BOTTLE in 1 CARTON (0093-7618-43) > 10 mL in 1 BOTTLE |
| Product NDC | 0093-7618 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dorzolamide Hydrochloride |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20100128 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | DORZOLAMIDE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |